In vitro activity of mannan sulfate, a novel sulfated polysaccharide, against human immunodeficiency virus type 1 and other enveloped viruses. 1989

M Ito, and M Baba, and K Hirabayashi, and T Matsumoto, and M Suzuki, and S Suzuki, and S Shigeta, and E De Clercq
Department of Bacteriology, Fukushima Medical College, Japan.

Mannan sulfate, a novel sulfated polysaccharide, was prepared and investigated for its activity against human immunodeficiency virus type 1 (HIV-1) in vitro. Mannan sulfate completely inhibited HIV-1-induced cell destruction and viral antigen expression in HIV-1-infected Molt-4 (clone 8) cells at a concentration of 4 micrograms/ml. The 50% antiviral effective doses obtained with mannan sulfate in Molt-4 (clone 8) cells and in MT-4 cells were 1.5 and 9.3 micrograms/ml, respectively. No toxicity for Molt-4 (clone 8) cells or MT-4 cells was observed at a concentration of 4,000 and 2,500 micrograms/ml, respectively. Mannan sulfate was also inhibitory to other enveloped viruses, i.e. herpes simplex virus types 1 and 2, vaccinia virus and vesicular stomatitis virus. These results suggest that mannan sulfate may be useful for the chemotherapy of various viral infections, including those causing and associated with AIDS.

UI MeSH Term Description Entries
D008351 Mannans Polysaccharides consisting of mannose units. Mannan
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014780 Viruses Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells. Animal Viruses,Zoophaginae,Animal Virus,Virus,Virus, Animal,Viruses, Animal
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

M Ito, and M Baba, and K Hirabayashi, and T Matsumoto, and M Suzuki, and S Suzuki, and S Shigeta, and E De Clercq
October 1995, International journal of biological macromolecules,
M Ito, and M Baba, and K Hirabayashi, and T Matsumoto, and M Suzuki, and S Suzuki, and S Shigeta, and E De Clercq
May 1998, Antiviral research,
M Ito, and M Baba, and K Hirabayashi, and T Matsumoto, and M Suzuki, and S Suzuki, and S Shigeta, and E De Clercq
December 1991, The Journal of infectious diseases,
M Ito, and M Baba, and K Hirabayashi, and T Matsumoto, and M Suzuki, and S Suzuki, and S Shigeta, and E De Clercq
June 1992, Virology,
M Ito, and M Baba, and K Hirabayashi, and T Matsumoto, and M Suzuki, and S Suzuki, and S Shigeta, and E De Clercq
November 1988, The Journal of infectious diseases,
M Ito, and M Baba, and K Hirabayashi, and T Matsumoto, and M Suzuki, and S Suzuki, and S Shigeta, and E De Clercq
April 2016, BMC microbiology,
M Ito, and M Baba, and K Hirabayashi, and T Matsumoto, and M Suzuki, and S Suzuki, and S Shigeta, and E De Clercq
January 1999, Antiviral chemistry & chemotherapy,
M Ito, and M Baba, and K Hirabayashi, and T Matsumoto, and M Suzuki, and S Suzuki, and S Shigeta, and E De Clercq
January 2014, Journal of virology,
M Ito, and M Baba, and K Hirabayashi, and T Matsumoto, and M Suzuki, and S Suzuki, and S Shigeta, and E De Clercq
April 1996, Journal of virology,
M Ito, and M Baba, and K Hirabayashi, and T Matsumoto, and M Suzuki, and S Suzuki, and S Shigeta, and E De Clercq
May 2013, Antiviral research,
Copied contents to your clipboard!